CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors

Authors: Christian Daniel Fankhauser, Lisa Roth, Nico Christian Grossmann, Benedikt Kranzbühler, Daniel Eberli, Tullio Sulser, Holger Moch, Peter-Karl Bode, Joerg Beyer, Thomas Hermanns

Source: BMC Cancer, Vol 19, Iss 1, Pp 1-6 (2019)

Subject Terms: Testicular germ cell tumor, Biomarkers, tumor, Prognosis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s12885-019-5961-1; https://doaj.org/toc/1471-2407

Access URL: https://doaj.org/article/0b9ab6ffffa847e9af22868c8611843a

Risk stratification for venous thromboembolism in patients with testicular germ cell tumors.

Authors: Angelika Bezan, Florian Posch, Ferdinand Ploner, Thomas Bauernhofer, Martin Pichler, Joanna Szkandera, Georg C Hutterer, Karl Pummer, Thomas Gary, Hellmut Samonigg, Joerg Beyer, Thomas Winder, Thomas Hermanns, Christian D Fankhauser, Armin Gerger, Michael Stotz

Source: PLoS ONE, Vol 12, Iss 4, p e0176283 (2017)

Subject Terms: Medicine, Science

File Description: electronic resource

Relation: http://europepmc.org/articles/PMC5400272?pdf=render; https://doaj.org/toc/1932-6203

Access URL: https://doaj.org/article/04305b8cf2fc405a86ba08b19f54474e